Immunotherapy versus targeted therapy in management of recurrent squamous cell carcinoma of oral tongue

Background: Targeted therapies, and more recently immunotherapy, have dramatically changed the landscape of treatments in oral cavity cancers and improved clinical outcomes. The benefit from targeted therapy and immune checkpoint inhibitors is however tampered by toxicities that affect different sit...

Full description

Saved in:
Bibliographic Details
Main Authors: Nadimul Hoda, Aastha Moza, K.P. Amith, K.S. Sabitha
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Oral Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906024002930
Tags: Add Tag
No Tags, Be the first to tag this record!